Drawing for RESCON

USPTO serial 76401012

RESCON

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
DALIER, JOHN DAVID
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RESCON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Melvin A. Hunn

MELVIN A HUNN HILL & HUNN LLP201 MAIN STSTE 1440FT WORTH, TX 76102

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of respiratory diseases and conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2003ABN1ABANDONMENT - EXPRESS MAILED—
Feb 20, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 20, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 15, 2002DOCKASSIGNED TO EXAMINER—
Aug 26, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance